Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. <i>Viruses</i> 2021, <i>13</i>, 539

Amantadine (1-amino-adamantane) is a versatile antiviral compound which has been licensed for decades against influenza viruses. During the Corona pandemic, its effect to inhibit SARS-CoV-2 in vitro has been investigated. However, an in vivo oral inapplicability was concluded due to ID₅₀...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Liv Bode, Detlef E. Dietrich, Carsten W. Spannhuth, Hanns Ludwig
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-02-01
Sarja:	Viruses
Aiheet:	amantadine human Borna disease virus in vitro in vivo antiviral
Linkit:	https://www.mdpi.com/1999-4915/14/3/494
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!